Letter to FDA: APC is focused on ethics

Published February 26, 2021

APC CEO Scott Brunner sent a letter this week to FDA’s acting director of its Office of Compounding Quality and Compliance, Gail Bormel. His message: APC is focused on compounder ethics, and has been working toward “encouraging and elevating the highest standards of ethical behavior among pharmacy compounders.”

From the updating, distribution, and promotion of the Pharmacy Compounding Professional’s Code of Ethics, to the publication of Pharmacy Compounding Leader, to the ethical-behavior focus on this year’s EduCon conference, Scott laid out the steps the association is taking — and plans to take — to assure patients are well cared for.

You can read the two-page letter here.